• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Dec31
Distribution Plan(EST)

Cash dividend 1.1726 USD

Dec13
Distribution Plan(EST)

Cash dividend 1.1726 USD

Distribution Plan(EST)

Cash dividend 1.1726 USD

View More

Event Tracking

Dec11
Wells Fargo Analyst Maintains Biogen Hold Rating With A Price Target Of $190
04:32
Wells Fargo Analyst Maintains Hold Rating on Regeneron Pharmaceuticals
04:26
Natera Announces Signatera MRD Test as Prognostic Biomarker for Breast Cancer Recurrence Risk
00:57
Dec10
HSBC downgrades Biogen's rating and target price leading to stock price decline
13:43
Bruker Receives $25 Million MRI Systems Orders
12:03
Cerity Partners LLC Increases Stake in Natera, Inc.
09:33